Banoxantrone: Phase Ib/IIa started

NOVC started an open-label Phase Ib/IIa trial in 60 patients

Read the full 107 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE